Global Oral Chemotherapy Market: Industry Analysis and Forecast (2020-2026) by Drug Class, Form, Distribution channel, and Region

Global Oral Chemotherapy Market size was valued at US$ XX Mn in 2019 and the total revenue is expected to grow at 8.0% through 2020 to 2026, reaching nearly US$ XX Mn. The global Oral Chemotherapy market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Oral Chemotherapy report also provides trends by market segments, technology, and investment with a competitive landscape. Global Oral Chemotherapy Market To know about the Research Methodology :- Request Free Sample Report

Global Oral Chemotherapy Market Overview:

Oral chemotherapy is a cancer-fighting drug given by oral route of administration in the form of a tablet, capsule, or liquid. Oral chemotherapy is recommended by the doctor, the physician's assistant has the same welfares and hazards as chemotherapy given by the Intravenous route of administration. Many cancer patients are receiving oral chemotherapy as a mode of treatment to avoid a less preferred intravenous route of administration by patients. Oral Chemotherapy account for 10% of total chemotherapy treatment nationwide and are typically placed in the most expensive price tier in insurance and medical care part D drug plans,

Global Oral Chemotherapy Market Dynamics:

Drivers, Development, and validation of oral chemotherapy drugs by FDA and regulatory agencies globally are driving the market with minimal side-effects and more convenient into this pandemic situation is driving the market at a high pace. Restrain, Increased Use of Oral Chemotherapy Drugs shoots amplified attention to patient compliance. Providing follow-up treatment to cancer patients after the surgery is an ongoing concern for the oncologist who loses control of medication administration when the patient moves from hospital to home. The complexity of cancer drug treatments challenges patients, who do not always understand missed doses, misunderstood package directions that lead to overdosing, and can lead to severe problems. Hence, Medication obedience with the physician's supervision is crucial in oncology to delay disease-free survival and progression-free survival. Opportunities, the increase in oral chemotherapy for the treatment of cancer offers many patients more convenient and less invasive treatment options compared to intravenous (IV) therapy administered in clinical settings acts as an opportunity to the market. This revolution in cancer treatment requires a new model for patient education, monitoring, and support – a model that depends on integration and collaboration among doctors, physicians, pharmacists, and other health care providers involved in patient care. Oral chemotherapy provides several advantages over the parenteral route of medication. Among the biggest advantages are patient convenience and flexibility in time location of administration acts as an opportunity for the key players to grow the market. Challenge Oral chemotherapy medication is a challenge for many patients and caregivers for many reasons, including side effects like fatigue, nausea, loss of appetite, diarrhea, weight loss, and easily prone to various diseases, finances, and lack of education and resources acts as a challenge for the key players in the market. Impact of COVID-19 The fact that patients with cancer are more susceptible to COVID-19 infection and its post complications have resulted in new challenges in managing cancer care delivery systems. Discontinuation of cancer treatment particularly in patients with advanced cancer due to lockdowns and conversion of cancer hospital to COVID-hospital in this high pandemic situation has crucially impacted the patient health. Although restrictions were trimmed in a phased manner from June 2020, and hospitals such as Tata Memorial offered a gleam of hope by operating 495 major cases in 5 weeks, 7 there is still a huge backlog of patients with cancer who need urgent care.

Global Oral Chemotherapy Market Segment Analysis:

By Drug Class, Non-steroidal aromatase inhibitor and protein kinase inhibitors collectively expected to gain mainstream revenue share of the oral chemotherapy market by drug class. Aromatase inhibitors work by blocking the enzyme aromatase, which turns the hormone androgen into small amounts of estrogen in the body. This means that less estrogen is available to stimulate the growth of hormone-receptor-positive breast cancer cells. By Form, the segment is categorized into tablets, capsules, liquid. In terms of form, the tablet is the leading segment with a 25.4% market share in 2019 in the pharmaceutical industries, followed by capsule being second dominating for oral chemotherapy market. Global Oral Chemotherapy Market By Distribution channel, hospital pharmacies are the dominating segment in terms of revenue USD 9.48 billion with a market share of 28.56. The factor responsible is the huge involvement of patient convenience as it is a one-stop solution for arranging consultation and medications. While retail pharmacies are second dominating and are expected to grow significantly. Global Oral Chemotherapy Market

Global Oral Chemotherapy Market Regional Insights:

North America is probable to be the most dominant region for the oral chemotherapy market due to the handiness of favorable repayment scenario in the U.S. and Canada for cancer treatment by oral chemotherapy. After North America, the oral chemotherapy market is then followed by Europe owing to the rising adoption of oral chemotherapy drugs by doctors in this region. Asia-Pacific is likely to show noteworthy growth for the oral chemotherapy market due to the rising frequency of cancer in India and China. Latin America and the Middle East and the Africa region are probable to show delayed growth for the oral chemotherapy market owing to a lack of mindfulness among the people in this region. The objective of the report is to present a comprehensive analysis of the global Oral Chemotherapy market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the global Oral Chemotherapy market dynamics, structure by analyzing the market segments and project the global Oral Chemotherapy market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global Oral Chemotherapy market make the report investor’s guide.

Global Oral Chemotherapy Market Scope: Inquire before buying

Global Oral Chemotherapy Market

Global Oral Chemotherapy Market, by Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Global Oral Chemotherapy Market Key Players

• Amgen Inc • Pfizer • Sanofi S.A., • Novartis AG • Johnson and Johnson, • Merck and CO. F. Hoffman-La Roche AG • Celegene Corporation • Bristol-Myers Squibb • Eli Lily and Company • Exelixis • Clovis Oncology, Inc. • Jazz Pharmaceuticals, Inc. • Puma Biotechnology • AbbVie Inc.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Oral Chemotherapy Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Oral Chemotherapy Market 3.4. Geographical Snapshot of the Oral Chemotherapy Market, By Manufacturer share 4. Global Oral Chemotherapy Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Drug Classs 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Oral Chemotherapy Market 5. Supply Side and Demand Side Indicators 6. Global Oral Chemotherapy Market Analysis and Forecast, 2019-2026 6.1. Global Oral Chemotherapy Market Size & Y-o-Y Growth Analysis. 7. Global Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 7.1.1. Non-Steroidal Aromatase Inhibitor 7.1.2. Protein Kinase Inhibitors 7.1.3. Anti-Androgens 7.1.4. Antineoplastic Agents 7.1.5. Alkylating Agents 7.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 7.2.1. Tablets 7.2.2. Capsules 7.2.3. Liquids 7.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 7.3.1. Hospital Pharmacies 7.3.2. Retail Pharmacies 7.3.3. Drug Stores 8. Global Oral Chemotherapy Market Analysis and Forecasts, By Region 1.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 1.1.1. North America 1.1.2. Europe 1.1.3. Asia-Pacific 1.1.4. Middle East & Africa 1.1.5. South America 9. Asia Pacific Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 9.1.1. Non-Steroidal Aromatase Inhibitor 9.1.2. Protein Kinase Inhibitors 9.1.3. Anti-Androgens 9.1.4. Antineoplastic Agents 9.1.5. Alkylating Agents 9.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 9.2.1. Tablets 9.2.2. Capsules 9.2.3. Liquids 9.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 9.3.1. Hospital Pharmacies 9.3.2. Retail Pharmacies 9.3.3. Drug Stores 10. North America Oral Chemotherapy Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 11.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 12. Canada Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 12.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 13. Mexico Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 13.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 14. Europe Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 14.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 15. Europe Oral Chemotherapy Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 16.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 17. France Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 17.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 18. Germany Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 18.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 19. Italy Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 19.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 20. Spain Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 20.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 21. Sweden Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 21.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 22. CIS Countries Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 22.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 23. Rest of Europe Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 23.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 24. Asia Pacific Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 24.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 25. Asia Pacific Oral Chemotherapy Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 26.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 27. India Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 27.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 28. Japan Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 28.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 29. South Korea Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 29.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 30. Australia Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 30.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 31. ASEAN Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 31.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 32. Rest of Asia Pacific Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 32.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 33. Middle East Africa Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 33.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 34. Middle East Africa Oral Chemotherapy Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 35.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 36. GCC Countries Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 36.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 37. Egypt Oral Chemotherapy e Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 37.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 38. Nigeria Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 38.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 39. Rest of ME&A Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 39.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 40. South America Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 40.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 41. South America Oral Chemotherapy Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 42.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 43. Argentina Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 43.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 44. Rest of South America Oral Chemotherapy Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Form, 2019-2026 44.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Oral Chemotherapy Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Drug Class and R&D Investment 45.2.2. New Drug Class Launches and Drug Class Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1.1. Pfizer, Inc., 45.3.1.1.1. Company Overview 45.3.1.1.2. Financial Overview 45.3.1.1.3. Geographic Footprint 45.3.1.1.4. Drug Class Portfolio 45.3.1.1.5. Business Strategy 45.3.1.1.6. Recent Developments 45.4. Amgen Inc 45.5. Sanofi S.A., 45.6. Novartis AG 45.7. Johnson and Johnson, 45.8. Merck and CO. F. Hoffman-La Roche AG 45.9. Celegene Corporation 45.10. Bristol-Myers Squibb 45.11. Eli Lily and Company 45.12. Exelixis 45.13. Clovis Oncology, Inc. 45.14. Jazz Pharmaceuticals, Inc. 45.15. Puma Biotechnology 45.16. AbbVie Inc. 46. Primary Key Insights

About This Report

Report ID 98685
Category Healthcare
Published Date May 2021
Updated Date
Contact Us